Cambridge Respiratory Innovations (CRI) creates ground-breaking respiratory technologies. In December 2020 it received funding from BGF and Downing Ventures to fast track research and development of its award-winning N-Tidal device to help medical professionals diagnose and monitor respiratory conditions. The N-Tidal device is a first-in-kind, connected, handheld capnometer incorporating unique patented sensor technology, that can accurately measure carbon dioxide levels in exhaled breath during normal breathing.
Business funding insights
Six financing options for businesses ready to grow
From private equity to crowdfunding, here’s our guide to financing options for established businesses and start-ups
BGF explains: our approach to quoted investments
With more than £500 million of quoted assets under management, BGF is an investor of scale in public markets, with a distinctive approach.